Methods of treatment using anti-erbb antibody-maytansinoid conjugates
Abstract:
The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anri-ErbB receptor antibody-maytansinoid conjugates.
Public/Granted literature
Information query
Patent Agency Ranking
0/0